Latest Breaking News On - Revixia life sciences - Page 1 : vimarsana.com

atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results, Reports on R&D Progress and Highlights Strategic Focus Areas of its Innovative Mental Health Platform

- Highlights included positive Phase 2b data with COMP360 from a ground-breaking treatment resistant depression (TRD) trial, highly encouraging Phase 2a proof-of-mechanism data with RL-007 in cognitive

New yorkUnited statesSan diegoCity ofUnited kingdomCamilla dormerSrinivas raoOtsuka pharmaceuticalsFellowship fund in psychedelic neuroscience at massachusettsRecognify life sciencesHospital centerRevixia life sciencesExchange commissionMultidisciplinary association for psychedelics studiesViridia life sciencesLife sciences

Insider Cannabis: Earnings, earnings, earnings

Insider Cannabis: Earnings, earnings, earnings
businessinsider.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com.au Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesPalm springsWestern australiaTom priceJonathan decourceyDonald trumpIrwin simonJeremy berkeJeffrey schultzYeji jesse leeNarbe alexandrianFeuerstein kulickAndrew cuomoKathy hochulMerida capital holdings

Insider Cannabis Newsletter: August 13

Insider Cannabis Newsletter: August 13
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesPalm springsJonathan decourceyDonald trumpIrwin simonJeffrey schultzYeji jesse leeJeremy berkeNarbe alexandrianBubba kushFeuerstein kulickAndrew cuomoTom priceKathy hochulMerida capital holdings

atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

New yorkUnited statesCity ofUnited kingdomAnne donohoeKarl hanesSalvinorina salSrinivas raoExchange commissionStrategic communicationsLife sciencesLife sciences nasdaqRevixia life sciencesGlenn shortIntrospect digital therapeuticsFlorian brand